BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6163624)

  • 1. Effect of intraventricular injection of neurotensin and other various bioactive peptides on plasma immunoreactive somatostatin levels in rat hypophysial portal blood.
    Abe H; Chihara K; Chiba T; Matsukura S; Fujita T
    Endocrinology; 1981 May; 108(5):1939-43. PubMed ID: 6163624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation by bombesin of immunoreactive somatostatin release into rat hypophysial portal blood.
    Abe H; Chihara K; Minamitani N; Iwasaki J; Chiba T; Matsukura S; Fujita T
    Endocrinology; 1981 Jul; 109(1):229-34. PubMed ID: 6113130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood.
    Chihara K; Minamitani N; Kaji H; Arimura A; Fujita T
    Endocrinology; 1981 Dec; 109(6):2279-81. PubMed ID: 6118262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive somatostatin in rat hypophysial portal blood.
    Gillioz P; Giraud P; Conte-Devolx B; Jaquet P; Codaccioni JL; Oliver C
    Endocrinology; 1979 May; 104(5):1407-10. PubMed ID: 436785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of substance P and neurotensin on somatostatin levels in rat portal plasma.
    Saito H; Saito S
    Endocrinology; 1980 Nov; 107(5):1600-5. PubMed ID: 6159202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of immunoreactive somatostatin release into hypophysial portal blood by electrical stimulation of the preoptic area in the rat.
    Chihara K; Arimura A; Kubli-Garfias C; Schally AV
    Endocrinology; 1979 Dec; 105(6):1416-8. PubMed ID: 499080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of substance P, neurotensin and the enkephalins on somatostatin release from the rat hypothalamus in vitro.
    Sheppard MC; Kronheim S; Pimstone BL
    J Neurochem; 1979 Feb; 32(2):647-9. PubMed ID: 762575
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoreactive vasoactive intestinal polypeptide in rat hypophysial portal blood.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1981 Feb; 108(2):395-8. PubMed ID: 7449730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucoregulatory effects of intrahypothalamic injections of bombesin and other peptides.
    Iguchi A; Matsunaga H; Nomura T; Gotoh M; Sakamoto N
    Endocrinology; 1984 Jun; 114(6):2242-6. PubMed ID: 6202499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation by serotonin of vasoactive intestinal polypeptide release into rat hypophysial portal blood.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1982 Jul; 111(1):338-40. PubMed ID: 7084118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neurotensin, substance P and methionine-enkephalin on colonic motility.
    Hellström PM; Rosell S
    Acta Physiol Scand; 1981 Oct; 113(2):147-54. PubMed ID: 6172002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine or capsaicin administration alters the secretion of beta-endorphin into the hypophysial portal vasculature of the rat.
    Koenig JI; Meltzer HY; Gudelsky GA
    Neuroendocrinology; 1986; 43(5):611-7. PubMed ID: 2944026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoreactive somatostatin in rat hypophysial portal blood (author's transl)].
    Gillioz P; Giraud P; Conte-Devolx B; Jaquet P; Codaccioni JL; Oliver C
    Ann Endocrinol (Paris); 1979; 40(4):435-6. PubMed ID: 518025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence that central neurotensin inhibits pituitary prolactin secretion by stimulating dopamine release from the hypothalamus.
    Tojo K; Kato Y; Kabayama Y; Ohta H; Inoue T; Imura H
    Proc Soc Exp Biol Med; 1986 Apr; 181(4):517-22. PubMed ID: 3485291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine in plasma of lateral and medial hypophysial portal vessels: evidence for regional variation in the release of hypothalamic dopamine into hypophysial portal blood.
    Reymond MJ; Speciale SG; Porter JC
    Endocrinology; 1983 Jun; 112(6):1958-63. PubMed ID: 6406205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostaglandin E1 on vasoactive intestinal polypeptide release from the hypothalamus and on prolactin secretion from the pituitary in rats.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Ohta H; Yanaihara N; Imura H
    Endocrinology; 1983 Dec; 113(6):2059-64. PubMed ID: 6685619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anesthetic dependence of the inhibitory effect of neurotensin on pentagastrin-stimulated acid secretion in rats. A possible role for somatostatin.
    Hammer RA; Fernandez C; Ertan A; Arimura A
    Life Sci; 1991; 48(4):333-9. PubMed ID: 1671292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intracerebroventricular administration of growth hormone-releasing factor and corticotropin-releasing factor on somatostatin secretion into rat hypophysial portal blood.
    Mitsugi N; Arita J; Kimura F
    Neuroendocrinology; 1990 Jan; 51(1):93-6. PubMed ID: 1968234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of various gastrointestinal peptides on gastric somatostatin release.
    Chiba T; Taminato T; Kadowaki S; Inoue Y; Mori K; Seino Y; Abe H; Chihara K; Matsukura S; Fujita T; Goto Y
    Endocrinology; 1980 Jan; 106(1):145-9. PubMed ID: 7349951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin as a mediator of the effect of neurotensin on pentagastrin-stimulated acid secretion in rats.
    Hammer RA; Ochoa A; Fernandez C; Ertan A; Arimura A
    Peptides; 1992; 13(6):1175-9. PubMed ID: 1362980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.